Simcere Pharmaceutical Group Limited

Business news, market intelligence, and global industry analysis.

The Latest

Flint Development wins Spotsylvania County approval for Patriot 95 logistics facility in Thornburg, VA

Arbor Energy signs 5 GW deal with GridMarket to supply zero-emission baseload power from 2029

Representative image of a construction project manager using AI-driven risk analysis, cost forecasting, and anomaly detection tools as Acumatica 2026 R1 expands construction ERP capabilities to help contractors spot margin pressure earlier.

Acumatica 2026 R1 brings AI-driven project risk tools to construction ERP as margin pressure intensifies

Why NUBURU, Inc.’s Phase I activation with Maddox Defense matters for U.S. defense supply-chain resilience (NYSE American: BURU)

Simcere’s SIM0278 enters Phase II trial in China: Could IL-2 Treg fusion therapy transform atopic dermatitis care?

Simcere’s SIM0278 enters Phase II in China for atopic dermatitis. Explore how its IL-2 Treg selectivity could redefine treatment for autoimmune skin diseases.

μFR system
αvβ6-integrin
α4β7 integrin
ZYUS Life Sciences
Zyrtec
Zyprexa Zydis
Zynga
Zynext Ventures USA LLC
Zynext Ventures
Zynex

November 11, 2025